Fierce Pharma

MARCH 28, 2024

An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. | An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. suggests intelligence officials and lawmakers may have good reason to be concerned about the CDMO’s potential political ties to its home country.

325

325

MedCity News

MARCH 28, 2024

The lack of adoption of interoperability tools by healthcare providers is a complex issue that requires a multi-faceted approach

Healthcare 127

Healthcare Healthcare Healthcare Provider 127

Fierce Pharma

MARCH 28, 2024

Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits that claim the company’s iconic baby powder can cause ovarian cancer. | Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits claiming that the company’s iconic baby powder can cause ovarian cancer. A New Jersey court ruled on Wednesday that J&J can contest the scientific findings that back those cases.

287

287

MedCity News

MARCH 28, 2024

Cancer drug developer Boundless Bio is a pioneer in therapies that target extrachromosomal DNA. The IPO cash will support its pipeline, including a lead program on track to report preliminary data later this year.

Leads 124

Leads Biopharma Pharma 124

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MARCH 28, 2024

Authors: | Gain the competitive edge with accurate probability of success assessments to uncover undervalued companies and early-stage assets for acquisitions.

Biopharma 258

Biopharma Competition 258

MedCity News

MARCH 28, 2024

One year after the Medicaid continuous enrollment provision ended, 19.2 million people have been disenrolled from Medicaid, according to KFF. This is higher than many expected, and experts have mixed reviews on how they think this process has gone.

121

121

Pharmaceutical Technology

MARCH 28, 2024

According to the CDC, over 64 cases of measles have been documented in the US in 2024, already exceeding 2023's total of 58.

113

113

Fierce Pharma

MARCH 28, 2024

[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides

Manufacturing 147

Manufacturing Pharmaceutical Leads 147

pharmaphorum

MARCH 28, 2024

Scientists say a test for motor neuron disease, based on an aptamer for biomarker TDP-43 in brain tissue, could detect at-risk people before symptoms develop.

111

111

Fierce Pharma

MARCH 28, 2024

Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. AstraZeneca is working to separate its supply chains for the U.S. and China. U.S. | Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. AstraZeneca is working to separate its supply chains for the U.S. and China.

Pharma 130

Pharma Marketing 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

MARCH 28, 2024

Moderna’s development of mRNA vaccines for influenza will be backed by up to $750m in funding from Blackstone in a risk-sharing deal

109

109

PharmaTimes

MARCH 28, 2024

Healthcare agencies can submit their entries free of charge with a deadline of 30 April

Healthcare 107

Healthcare Healthcare 107

pharmaphorum

MARCH 28, 2024

New data for Beckley Psytech's psychedelic therapy for treatment-resistant depression builds anticipation for a phase 2b readout later this year

105

105

PharmaTimes

MARCH 28, 2024

The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases

106

106

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Commerce

MARCH 28, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma FDA 105

pharmaphorum

MARCH 28, 2024

Akebia’s Vafseo has been approved in the US as a treatment for anaemia caused by chronic kidney disease in dialysis patients, the first direct rival to GSK’s Jesduvroq.

Marketing 104

Marketing Patients 104

European Pharmaceutical Review

MARCH 28, 2024

A paper published in Applied Sciences has described a quality risk assessment methodology for application in sterile PET radiopharmaceutical production under Good Manufacturing Practice (GMP) regulations. According to research highlighted in the paper, applying quality standards such as GMP and ISO 9001 “guarantees the quality and safety of a radiopharmaceutical and contributes to optimising the performance and efficacy of the entire production process.

Management 98

Management Safety Manufacturing Medicine 98

pharmaphorum

MARCH 28, 2024

Study finds AI analysis of Google Street View images could reveal how built environment factors affect the risk of cardiovascular disease

103

103

Advertisement

Pharmaceutical Technology

MARCH 28, 2024

Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with retinitis pigmentosa (RP).

Patients 98

Patients 98

European Pharmaceutical Review

MARCH 28, 2024

The global pharmaceutical and biotechnology environmental monitoring market valued $24 billion in 2023, according to a report by Verified Market Research. This figure is projected to increase to $38.1 billion by 2030. Pharmaceutical and biotechnology environmental monitoring market Influencing factors The report also covered that due to the biotechnology industry requiring sterile conditions and products, expansion of this sector creates demand for extensive environmental monitoring.

Pharmaceutical 98

Pharmaceutical Marketing Pharma Management 98

MedCity News

MARCH 28, 2024

This technology can result in reduced readmission rates, increased patient satisfaction, and a consistent flow of post-acute care revenue, especially in rural areas.

Patients 97

Patients 97

PharmaTimes

MARCH 28, 2024

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

Leads 97

Leads Electronics Medicine 97

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

MedCity News

MARCH 28, 2024

Here is a list of some of the most notable funding round announcements that took place this March in the provider technology space.

Medical 69

Medical Healthcare Healthcare 69

Pharmaceutical Technology

MARCH 28, 2024

Boundless has two assets in clinical trials targeting extrachromosomal DNA in cancer patients.

Marketing 59

Marketing Patients 59

Pharmacy Times

MARCH 28, 2024

As the full act will be enforced in November 2024, all medication dispensers must ensure they’re fully prepared.

Medical 55

Medical 55

Pharmaceutical Technology

MARCH 28, 2024

AI is fast becoming a valuable tool for developers of regulated health apps. In an exclusive Q&A, SaMD solutions provider Huma tells us how AI is allowing clinicians to make better decisions and why the human factor will remain a critical element of healthcare.

Medical 59

Medical Healthcare Healthcare 59

Advertisement

Distribution

Scott’s Directories

MARCH 28, 2024

Advertising has come a long way from traditional methods, becoming increasingly sophisticated and data-driven in today’s digital landscape. One of the most impactful strategies is using search keywords for targeted advertising. By understanding and effectively utilizing these keywords, businesses can greatly enhance their ad reach and engagement. This blog by MD Select explores the nuances of using search keywords, with a focus on geo targeting display ads and their transformative potential for

Competition 52

Competition Leads Medical Marketing 52

PharmaVoice

MARCH 28, 2024

With Zola Therapeutics, Krieg plans to design and sell a series of cancer immunotherapies without the help of outside investors, he told BioPharma Dive.

Biopharma 52

Biopharma 52

PharmaTech

MARCH 28, 2024

Univercells and Altamira Therapeutics are collaborating on nanoparticle-delivered mRNA vaccines, while Andelyn Biosciences and Grace Science are partnering on novel therapies for NGLY1 deficiency.

52

52

PharmExec

MARCH 28, 2024

Approval of Vafsen (vadadustat) based on promising results from the INNO2VATE program and additional safety data from use in Japan in adults with chronic kidney disease.

Safety 52

Safety FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales